Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo... von Thomas Foltynie, Rachael Hunter, Lynn Rochester, Dilan Athauda, Patricia Limousin, Alexa King, Simon Skene, Kashfia Chowdhury, Camille B Carroll, Huw Morris, Michele T Hu, Monty Silverdale, Rachel Gibson, Marisa Chau, Christine Lo, Nirosen Vijiaratnam, Christine Girges, Grace Auld, Kate Maclagan, Steve Hibbert, Gordon W Duncan, Ray Chaudhuri, Silvia Del Din, Alison J Yarnall, John Dickson, Vincenzo Libri

Volltext